• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

NIH

Mass layoffs start at HHS: ‘FDA as we’ve known it is finished’

April 1, 2025 By Jim Hammerand

The Trump Administration has started mass layoffs at the FDA, CDC, NIH and other agencies within the Department of Health and Human Services, following up on a plan announced last week for Elon Musk’s DOGE team to shrink the workforce by 20,000 people through voluntary separations and new terminations. UPDATE: FDA’s chief medical officer is […]

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: CDC, Centers for Medicare and Medicaid Services, FDA, imports, Layoffs, NIH, tariffs, taxes, U.S. Department of Health and Human Services

Trump taps RFK Jr. to run HHS — but two groups could block him

November 15, 2024 By Jim Hammerand

President-elect Donald Trump says he wants Robert F. Kennedy Jr. to serve as secretary of the U.S. Department of Health and Human Services (HHS), giving him oversight of the FDA, CMS, CDC, NIH and other critical health agencies and functions. It’s not clear yet whether Republicans in the U.S. Senate would confirm Kennedy’s appointment given […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: CDC, FDA, NIH, U.S. Department of Health and Human Services

RFK Jr. says he wants to eliminate ‘entire departments’ at FDA under Trump

November 6, 2024 By Jim Hammerand

Robert F. Kennedy Jr. — who claims President-elect Donald Trump promised him “control” of the U.S. Department of Health and Human Services and agencies including the FDA, CDC and NIH — today said that there are FDA departments that “have to go.” “There are entire departments like the nutrition department at the FDA … that […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: CDC, FDA, NIH, U.S. Department of Health and Human Services

RFK Jr. says he’ll control FDA and Health and Human Services if Trump wins

October 30, 2024 By Jim Hammerand

Robert F. Kennedy Jr. says former President Donald Trump promised him “control” of the U.S. Department of Health and Human Services and its agencies — including the FDA, CDC and NIH — if Trump returns to office. In August, Trump said he would consider adding Kennedy to his administration’s second term if Kennedy ended his […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: CDC, FDA, NIH, U.S. Department of Health and Human Services

NIH funds Illinois Tech project using machine learning to fully automate insulin delivery

December 9, 2022 By Sean Whooley

Researchers at Illinois Institute of Technology received $1.2 million from the NIH to develop a machine learning system for an artificial pancreas’ insulin delivery. Chemical engineering professor Ali Cinar leads the project to ease the burden on those with type 1 diabetes. NIH funding covers four years for developing the machine learning system. The researchers […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Funding Roundup, Health Technology, Patient Monitoring, Research & Development, Software / IT Tagged With: Illinois Institute of Technology, Illinois Tech, National Institutes of Health (NIH), NIH

Rescue Biomedical wins $2.8M grant for nalaxone-releasing implant for opioid overdoses

October 6, 2022 By Sean Whooley

Rescue Biomedical announced today that it received a $2.8 million grant from the National Institutes of Health for its opioid overdose treatment. West Lafayette, Indiana received a Fast-Track Small Business Innovation Research, or SBIR, grant from the NIH. The company develops technology that detects when a person is overdosing on an opioid and delivers naloxone […]

Filed Under: Business/Financial News, Drug-Device Combinations, Funding Roundup, Implants, Pharmaceutical Tagged With: National Institutes of Health (NIH), NIH, Purdue, Rescue Biomedical

NIH to launch clinical trial of three mRNA HIV vaccines

March 14, 2022 By Brian Buntz

The National Institute of Allergy and Infectious Diseases (NIAID) has announced a Phase 1 clinical study of HIV vaccines using mRNA sequences. The study will test the safety and immunogenicity of three investigational HIV mRNA vaccines known as BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA and BG505 MD39.3 gp151 CD4KO mRNA. Get the full story […]

Filed Under: Blog, Health Information Technology, Pharmaceutical Tagged With: HIV, Moderna, National Institute of Allergy and Infectious Diseases, NIAID, NIH

NIH launches $9.8M neuromodulation competition

January 18, 2022 By Sean Whooley

The National Institutes of Health (NIH) announced today that it launched the first phase of its Neuromod Prize competition. Neuromod Prize, a $9.8 million competition, aims to accelerate the development of neuromodulation therapies. NIH seeks scientists, engineers and clinicians to submit novel concepts and clinical development plans to demonstrate solutions for stimulating the peripheral nervous […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Pain Management, Research & Development Tagged With: National Institutes of Health (NIH), NIH

NIH director Francis Collins to step down

October 5, 2021 By Sean Whooley

The National Institutes of Health (NIH) announced today that Dr. Francis S. Collins will step down as director of the agency. Collins, the longest-serving presidentially-appointed NIH director, decided to end his tenure by the end of the year. He had served three U.S. presidents over more than 12 years. NIH did not announce a successor […]

Filed Under: Business/Financial News, Featured, Research & Development Tagged With: National Institutes of Health (NIH), NIH, Personnel Moves

NIH launches study of allergic reactions to COVID-19 vaccines

April 7, 2021 By Chris Newmarker

The NIH today announced that a clinical trial is underway to study whether people who are highly allergic or have a mast cell disorder are more likely to develop an allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. Reports of severe allergic reactions to COVID-19 vaccines have made headlines since the rollout to the […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine trial, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Pfizer

NIH announces more than $98M in contracts for new COVID-19 testing tech

October 7, 2020 By Chris Newmarker

The National Institutes of Health today announced six new contracts worth $98.35 million for COVID-19 testing approaches to improve sample collection, processing and results. NIH awarded the contracts in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) as part of the Rapid Acceleration of Diagnostics (RADx) initiative. They cover innovations including integration with […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup Tagged With: coronavirus, COVID-19, Ellume, Flambeau Diagnostics, Luminostics, NIH, Quanterix Corp., U.S. Biomedical Advanced Research and Development Authority (BARDA), Ubiquitome, Visby Medical

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy